EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JAN 2022
TABLES
22
PAGES
93
EDITION
8
PRICE
USD 5600
CODE
MCP22701
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What's New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
SELECT PLAYERS
Abcam plc; Active Motif, Inc.; Affinity Biologicals, Inc.; Agilent Technologies, Inc.; BD; Beckman Coulter, Inc.; Bethyl Laboratories, Inc.; Bio SB; BioLegend, Inc.; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; Enzo Life Sciences, Inc.; F. Hoffmann-La Roche Ltd; GenScript; Jackson ImmunoResearch Inc.; Lonza; Merck KGaA; Miltenyi Biotec; OriGene Technologies, Inc.; PerkinElmer Inc.; QIAGEN; Rockland Immunochemicals, Inc.; Sysmex Corporation; Thermo Fisher Scientific Inc.
SEGMENTS
» Engine Placement (Outboard, Inboard, Other Engine Placements) » Boat Type (Yachts, Sailboats, Personal Watercrafts, Inflatables, Other Boat Types) » Activity (Cruising / Watersports, Fishing) » Material Type (Aluminum, Fiberglass, Steel, Other Material Types)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Impact of Covid-19 and a Looming Global Recession |
Research Antibodies – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Research Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Research Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Reagent by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Reagent by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Academic & Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Academic & Research Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Western Blotting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Western Blotting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Flow Cytometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Flow Cytometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Enzyme-Linked Immunosorbent Assay (ELISA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Enzyme-Linked Immunosorbent Assay (ELISA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Immunofluorescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Immunofluorescence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Immunoprecipitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Immunoprecipitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Research Antibodies Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027 |
World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Immunology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Immunology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Neurobiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Neurobiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
Research Antibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
USA Recent Past, Current & Future Analysis for Research Antibodies by Product - Reagent and Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA 7-Year Perspective for Research Antibodies by Product - Percentage Breakdown of Value Sales for Reagent and Antibodies for the Years 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Research Antibodies by End-Use - Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA 7-Year Perspective for Research Antibodies by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations for the Years 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Research Antibodies by Technology - Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA 7-Year Perspective for Research Antibodies by Technology - Percentage Breakdown of Value Sales for Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies for the Years 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Research Antibodies by Application - Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA 7-Year Perspective for Research Antibodies by Application - Percentage Breakdown of Value Sales for Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications for the Years 2021 & 2027 |
CANADA |
Canada Recent Past, Current & Future Analysis for Research Antibodies by Product - Reagent and Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada 7-Year Perspective for Research Antibodies by Product - Percentage Breakdown of Value Sales for Reagent and Antibodies for the Years 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Research Antibodies by End-Use - Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada 7-Year Perspective for Research Antibodies by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations for the Years 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Research Antibodies by Technology - Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada 7-Year Perspective for Research Antibodies by Technology - Percentage Breakdown of Value Sales for Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies for the Years 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Research Antibodies by Application - Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada 7-Year Perspective for Research Antibodies by Application - Percentage Breakdown of Value Sales for Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications for the Years 2021 & 2027 |
JAPAN |
Research Antibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
Japan Recent Past, Current & Future Analysis for Research Antibodies by Product - Reagent and Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan 7-Year Perspective for Research Antibodies by Product - Percentage Breakdown of Value Sales for Reagent and Antibodies for the Years 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Research Antibodies by End-Use - Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan 7-Year Perspective for Research Antibodies by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations for the Years 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Research Antibodies by Technology - Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan 7-Year Perspective for Research Antibodies by Technology - Percentage Breakdown of Value Sales for Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies for the Years 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Research Antibodies by Application - Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan 7-Year Perspective for Research Antibodies by Application - Percentage Breakdown of Value Sales for Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications for the Years 2021 & 2027 |
CHINA |
Research Antibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
China Recent Past, Current & Future Analysis for Research Antibodies by Product - Reagent and Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China 7-Year Perspective for Research Antibodies by Product - Percentage Breakdown of Value Sales for Reagent and Antibodies for the Years 2021 & 2027 |
China Recent Past, Current & Future Analysis for Research Antibodies by End-Use - Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China 7-Year Perspective for Research Antibodies by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations for the Years 2021 & 2027 |
China Recent Past, Current & Future Analysis for Research Antibodies by Technology - Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China 7-Year Perspective for Research Antibodies by Technology - Percentage Breakdown of Value Sales for Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies for the Years 2021 & 2027 |
China Recent Past, Current & Future Analysis for Research Antibodies by Application - Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China 7-Year Perspective for Research Antibodies by Application - Percentage Breakdown of Value Sales for Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications for the Years 2021 & 2027 |
EUROPE |
Research Antibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
Europe Recent Past, Current & Future Analysis for Research Antibodies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
Europe 7-Year Perspective for Research Antibodies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Research Antibodies by Product - Reagent and Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe 7-Year Perspective for Research Antibodies by Product - Percentage Breakdown of Value Sales for Reagent and Antibodies for the Years 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Research Antibodies by End-Use - Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe 7-Year Perspective for Research Antibodies by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations for the Years 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Research Antibodies by Technology - Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe 7-Year Perspective for Research Antibodies by Technology - Percentage Breakdown of Value Sales for Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies for the Years 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Research Antibodies by Application - Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe 7-Year Perspective for Research Antibodies by Application - Percentage Breakdown of Value Sales for Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications for the Years 2021 & 2027 |
FRANCE |
Research Antibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
France Recent Past, Current & Future Analysis for Research Antibodies by Product - Reagent and Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France 7-Year Perspective for Research Antibodies by Product - Percentage Breakdown of Value Sales for Reagent and Antibodies for the Years 2021 & 2027 |
France Recent Past, Current & Future Analysis for Research Antibodies by End-Use - Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France 7-Year Perspective for Research Antibodies by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations for the Years 2021 & 2027 |
France Recent Past, Current & Future Analysis for Research Antibodies by Technology - Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France 7-Year Perspective for Research Antibodies by Technology - Percentage Breakdown of Value Sales for Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies for the Years 2021 & 2027 |
France Recent Past, Current & Future Analysis for Research Antibodies by Application - Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France 7-Year Perspective for Research Antibodies by Application - Percentage Breakdown of Value Sales for Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications for the Years 2021 & 2027 |
GERMANY |
Research Antibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
Germany Recent Past, Current & Future Analysis for Research Antibodies by Product - Reagent and Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany 7-Year Perspective for Research Antibodies by Product - Percentage Breakdown of Value Sales for Reagent and Antibodies for the Years 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Research Antibodies by End-Use - Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany 7-Year Perspective for Research Antibodies by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations for the Years 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Research Antibodies by Technology - Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany 7-Year Perspective for Research Antibodies by Technology - Percentage Breakdown of Value Sales for Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies for the Years 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Research Antibodies by Application - Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany 7-Year Perspective for Research Antibodies by Application - Percentage Breakdown of Value Sales for Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications for the Years 2021 & 2027 |
ITALY |
Italy Recent Past, Current & Future Analysis for Research Antibodies by Product - Reagent and Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy 7-Year Perspective for Research Antibodies by Product - Percentage Breakdown of Value Sales for Reagent and Antibodies for the Years 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Research Antibodies by End-Use - Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy 7-Year Perspective for Research Antibodies by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations for the Years 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Research Antibodies by Technology - Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy 7-Year Perspective for Research Antibodies by Technology - Percentage Breakdown of Value Sales for Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies for the Years 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Research Antibodies by Application - Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy 7-Year Perspective for Research Antibodies by Application - Percentage Breakdown of Value Sales for Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications for the Years 2021 & 2027 |
UNITED KINGDOM |
Research Antibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
UK Recent Past, Current & Future Analysis for Research Antibodies by Product - Reagent and Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK 7-Year Perspective for Research Antibodies by Product - Percentage Breakdown of Value Sales for Reagent and Antibodies for the Years 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Research Antibodies by End-Use - Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK 7-Year Perspective for Research Antibodies by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations for the Years 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Research Antibodies by Technology - Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK 7-Year Perspective for Research Antibodies by Technology - Percentage Breakdown of Value Sales for Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies for the Years 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Research Antibodies by Application - Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK 7-Year Perspective for Research Antibodies by Application - Percentage Breakdown of Value Sales for Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications for the Years 2021 & 2027 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Research Antibodies by Product - Reagent and Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe 7-Year Perspective for Research Antibodies by Product - Percentage Breakdown of Value Sales for Reagent and Antibodies for the Years 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Research Antibodies by End-Use - Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe 7-Year Perspective for Research Antibodies by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations for the Years 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Research Antibodies by Technology - Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe 7-Year Perspective for Research Antibodies by Technology - Percentage Breakdown of Value Sales for Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies for the Years 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Research Antibodies by Application - Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe 7-Year Perspective for Research Antibodies by Application - Percentage Breakdown of Value Sales for Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications for the Years 2021 & 2027 |
ASIA-PACIFIC |
Research Antibodies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Research Antibodies by Product - Reagent and Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific 7-Year Perspective for Research Antibodies by Product - Percentage Breakdown of Value Sales for Reagent and Antibodies for the Years 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Research Antibodies by End-Use - Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific 7-Year Perspective for Research Antibodies by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations for the Years 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Research Antibodies by Technology - Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific 7-Year Perspective for Research Antibodies by Technology - Percentage Breakdown of Value Sales for Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies for the Years 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Research Antibodies by Application - Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific 7-Year Perspective for Research Antibodies by Application - Percentage Breakdown of Value Sales for Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications for the Years 2021 & 2027 |
REST OF WORLD |
Rest of World Recent Past, Current & Future Analysis for Research Antibodies by Product - Reagent and Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World 7-Year Perspective for Research Antibodies by Product - Percentage Breakdown of Value Sales for Reagent and Antibodies for the Years 2021 & 2027 |
Rest of World Recent Past, Current & Future Analysis for Research Antibodies by End-Use - Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World 7-Year Perspective for Research Antibodies by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutions and Contract Research Organizations for the Years 2021 & 2027 |
Rest of World Recent Past, Current & Future Analysis for Research Antibodies by Technology - Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World 7-Year Perspective for Research Antibodies by Technology - Percentage Breakdown of Value Sales for Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation and Other Technologies for the Years 2021 & 2027 |
Rest of World Recent Past, Current & Future Analysis for Research Antibodies by Application - Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World 7-Year Perspective for Research Antibodies by Application - Percentage Breakdown of Value Sales for Oncology, Infectious Diseases, Immunology, Stem Cells, Neurobiology and Other Applications for the Years 2021 & 2027 |
IV. COMPETITION |
Total Companies Profiled: 42 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com